Nov. 25, 2025 — Remington Medical announced U.S. Food and Drug Administration 510(k) clearance and the commercial release of the second-generation VascuChek Doppler, a cordless handheld vascular device designed for clinical and surgical use.
VascuChek 2.0 retains the original model’s compact, handheld transceiver and detachable disposable probe, which connects to the unit in a manner likened to an electric toothbrush attaching to its handle.
The updated model adds a Bluetooth external speaker — housed in the device’s charging base — to improve audio clarity and volume during intraoperative blood-flow assessment. The device also includes two internal speakers for real-time, on-device audio.
Remington highlights that VascuChek’s single-use probes feature a patented antiseptic sheath. That combination makes the system, the company says, the only wireless handheld Doppler cleared by the FDA for evaluating intraoperative and subcutaneous blood flow within a sterile surgical field.
“When it launched in 2022, VascuChek was a big leap forward for convenience and ease, offering surgeons a cordless Doppler that gave them full control,” said Attly Aycock, CEO of Remington Medical.
“The new device builds on that and adds even better audio clarity and volume; we made these updates based on valuable feedback from surgeons who’ve been using VascuChek in their ORs. We’re confident that VascuChek can transform operational efficiencies for the more than 38,000 operating rooms across the U.S.”
Primary users include vascular, cardiac, orthopedic and podiatric surgeons, cardiologists, and surgical nurses. Remington said VascuChek 2.0 is available for sale in the United States.
